Katherine A. Scilla
Hematology Oncology | Oncology
22 South Greene Street
Floor 1
Baltimore, MD 21201
Floor 1
Baltimore, MD 21201
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Brief Report: Multi-Institution Real-World Analysis Evaluating Safety, Efficacy, and ctDNA Dynamics After Tarlatamab in Patients With Previously Treated SCLC and LCNEC.
Journal: JTO clinical and research reports
Published: September 02, 2025
Prospective Multicenter Study Evaluating a Combined Circulating Tumor DNA and Circulating Tumor RNA Liquid Biopsy in Metastatic Non-Small Cell Lung Cancer (LIQUIK).
Journal: JCO precision oncology
Published: June 26, 2025
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 27, 2023
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 21, 2023
Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299.
Journal: JTO clinical and research reports
Published: June 30, 2023
Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer Through Liquid Biopsy: Management of C797S Acquired Mutation.
Journal: Clinical lung cancer
Published: April 01, 2023
Laying the Foundation for a Mesothelioma Patient Registry: Development of Data Collection Tools.
Journal: International journal of environmental research and public health
Published: January 30, 2023
The Effect of Body Mass Index and Residence in Food Priority Areas on Patterns-of-Care and Cancer Outcomes in Patients With Stage III Non-Small Cell Lung Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: November 11, 2022
Development of autoimmune diabetes with severe diabetic ketoacidosis and immune-related thyroiditis secondary to durvalumab: a case report.
Journal: Translational lung cancer research
Published: November 19, 2020
Immunotherapy in Lung Cancer: From a Minor God to the Olympus.
Journal: Advances in experimental medicine and biology
Published: April 18, 2020
New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1).
Journal: Current oncology reports
Published: April 17, 2020
Is There Room for Personalized Medicine in Small-Cell Lung Cancer (SCLC)? Remarkable Activity of Pazopanib in Refractory FGFR1-Amplified ED-SCLC.
Journal: JCO precision oncology
Published: December 01, 2019
Last Updated: 09/26/2026